Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Igor Krisch"'
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 369:576-582
Various dopaminergic drugs have been studied for their efficacy in the treatment of cocaine addiction. Pretreatment with either selective dopamine D1 receptor agonists or selective dopamine D2 receptor antagonists prevents reinstatement of cocaine-se
Autor:
Igor Legen, Sabine Kopp, Bertil Abrahamsson, Luka Peternel, Klara Megušar, D.W. Groot, Igor Krisch, Rodrigo Cristofoletti, Mehul Mehta, Vinod P. Shah, Sandra Berglez, James E. Polli, Peter Langguth, Marija Petrusevska, Jennifer B. Dressman
Publikováno v:
Journal of pharmaceutical sciences. 104(9)
Literature and experimental data relevant for the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing levetiracetam are reviewed. Data on solubility and perme
Publikováno v:
European Journal of Pharmacology. 369:43-47
The qualitative and quantitative effects of the (+)-S and (-)-R enantiomers and of the racemic mixture of the Ca2+ channel antagonist, nicardipine, were compared on the isolated porcine coronary artery with intact and removed endothelium. All three f
Publikováno v:
CNS Drug Reviews. 2:294-307
Publikováno v:
Pharmacology. 45:195-208
In a structure-activity study, carried out in rabbit isolated aorta, the effect of different structural modifications in the ergoline nucleus upon the activity at 5-HT2 receptors and α-adre
Autor:
Igor Krisch, Breda Bole-Vunduk
Publikováno v:
Pharmacology, biochemistry, and behavior. 47(2)
The 5-HT1A receptor-mediated tail flick response in rats and the 5-HT2 receptor-mediated head twitch response in mice were used to study the functional activity of a new ergoline derivative, 9,10-didehydro-N-(2-propynyl)-6-methylergoline-8β-carboxam